| Symbol |
Name |
|
AAA1
|
aortic aneurysm, familial abdominal 1
|
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACAP3
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACSF3
|
acyl-CoA synthetase family member 3
|
|
ACSM3
|
acyl-CoA synthetase medium-chain family member 3
|
|
ACTBP2
|
actin, beta pseudogene 2
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR2A
|
activin A receptor, type IIA
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific)
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
ADAP2
|
ArfGAP with dual PH domains 2
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRB3
|
adhesion G protein-coupled receptor B3
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AK6
|
adenylate kinase 6
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1L1
|
aldehyde dehydrogenase 1 family, member L1
|
|
ALDH1L2
|
aldehyde dehydrogenase 1 family, member L2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A2
|
aldehyde dehydrogenase 3 family, member A2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
AMELX
|
amelogenin, X-linked
|
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
|
AMPH
|
amphiphysin
|
|
ANIB1
|
aneurysm, intracranial berry 1
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
AP1B1
|
adaptor-related protein complex 1, beta 1 subunit
|
|
AP2A1
|
adaptor-related protein complex 2, alpha 1 subunit
|
|
AP2A2
|
adaptor-related protein complex 2, alpha 2 subunit
|
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA1BP
|
apolipoprotein A-I binding protein
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APOL3
|
apolipoprotein L, 3
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARF5
|
ADP-ribosylation factor 5
|
|
ARG1
|
arginase 1
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARL15
|
ADP-ribosylation factor-like 15
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRDC3
|
arrestin domain containing 3
|
|
ARSI
|
arylsulfatase family, member I
|
|
ASB10
|
ankyrin repeat and SOCS box containing 10
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ASIP
|
agouti signaling protein
|
|
ASL
|
argininosuccinate lyase
|
|
ASPN
|
asporin
|
|
ASRGL1
|
asparaginase like 1
|
|
ATD
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
ATF6
|
activating transcription factor 6
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP5H
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d
|
|
ATP6V1H
|
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATPAF2
|
ATP synthase mitochondrial F1 complex assembly factor 2
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRN
|
attractin
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN7
|
ataxin 7
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BCAN
|
brevican
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST2
|
bestrophin 2
|
|
BFSP2
|
beaded filament structural protein 2, phakinin
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIN1
|
bridging integrator 1
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCA3
|
breast cancer 3
|
|
BRCATA
|
Breast cancer, 11;22 translocation associated
|
|
BRD2
|
bromodomain containing 2
|
|
BRK1
|
BRICK1, SCAR/WAVE actin-nucleating complex subunit
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSN
|
bassoon presynaptic cytomatrix protein
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
|
C4BPB
|
complement component 4 binding protein, beta
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C5ORF30
|
chromosome 5 open reading frame 30
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA1
|
carbonic anhydrase I
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CADM3
|
cell adhesion molecule 3
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAND1
|
cullin-associated and neddylation-dissociated 1
|
|
CAPN10
|
calpain 10
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBR1
|
carbonyl reductase 1
|
|
CBR3
|
carbonyl reductase 3
|
|
CBX3
|
chromobox homolog 3
|
|
CBX5
|
chromobox homolog 5
|
|
CBX8
|
chromobox homolog 8
|
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding)
|
|
CCDC26
|
CCDC26 long non-coding RNA
|
|
CCDC28B
|
coiled-coil domain containing 28B
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCDC88B
|
coiled-coil domain containing 88B
|
|
CCK
|
cholecystokinin
|
|
CCKAR
|
cholecystokinin A receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD226
|
CD226 molecule
|
|
CD247
|
CD247 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD6
|
CD6 molecule
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2A-AS1
|
CDKN2A antisense RNA 1 (head to head)
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa
|
|
CEACAM16
|
carcinoembryonic antigen-related cell adhesion molecule 16
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CELSR2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
|
CEP290
|
centrosomal protein 290kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFDP1
|
craniofacial development protein 1
|
|
CFH
|
complement factor H
|
|
CFI
|
complement factor I
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGNL1
|
cingulin-like 1
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD6
|
chromodomain helicase DNA binding protein 6
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHIC2
|
cysteine-rich hydrophobic domain 2
|
|
CHN1
|
chimerin 1
|
|
CHRFAM7A
|
CHRNA7 (cholinergic receptor, nicotinic, alpha 7, exons 5-10) and FAM7A (family with sequence similarity 7A, exons A-E) fusion
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLDN5
|
claudin 5
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
|
CLINT1
|
clathrin interactor 1
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CMA1
|
chymase 1, mast cell
|
|
CMD1B
|
cardiomyopathy, dilated 1B (autosomal dominant)
|
|
CMTX3
|
Charcot-Marie-Tooth neuropathy, X-linked 3 (dominant)
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNNM2
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTNAP1
|
contactin associated protein 1
|
|
COCH
|
cochlin
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL25A1
|
collagen, type XXV, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPD
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
CORIN
|
corin, serine peptidase
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRELD2
|
cysteine-rich with EGF-like domains 2
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRY2
|
cryptochrome circadian clock 2
|
|
CRYAA
|
crystallin, alpha A
|
|
CSAG2
|
CSAG family, member 2
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
CST3
|
cystatin C
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
|
CTRCT37
|
Cataract, congenital cerulean type, 5
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2B7P
|
cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAO
|
D-amino-acid oxidase
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DBET
|
D4Z4 binding element transcript (non-protein coding)
|
|
DBF4
|
DBF4 zinc finger
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DCTN1
|
dynactin 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDX10
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10
|
|
DDX11
|
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11
|
|
DDX54
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 54
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DEL10Q26
|
Chromosome 10q deletion syndrome
|
|
DENND1B
|
DENN/MADD domain containing 1B
|
|
DEPDC5
|
DEP domain containing 5
|
|
DFNA18
|
deafness, autosomal dominant 18
|
|
DFNA24
|
deafness, autosomal dominant 24
|
|
DFNA53
|
deafness, autosomal dominant 53
|
|
DFNB33
|
deafness, autosomal recessive 33
|
|
DFNB45
|
deafness, autosomal recessive 45
|
|
DFNB55
|
deafness, autosomal recessive 55
|
|
DGCR6
|
DiGeorge syndrome critical region gene 6
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DHFR
|
dihydrofolate reductase
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLST
|
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)
|
|
DLX3
|
distal-less homeobox 3
|
|
DLX5
|
distal-less homeobox 5
|
|
DLX6
|
distal-less homeobox 6
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2
|
|
DNM2
|
dynamin 2
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPCR1
|
diffuse panbronchiolitis critical region 1
|
|
DPH3
|
diphthamide biosynthesis 3
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DPY19L2
|
dpy-19-like 2 (C. elegans)
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
DUP22Q11.2
|
Chromosome 22q11.2 microduplication syndrome
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DUSP9
|
dual specificity phosphatase 9
|
|
DYT17
|
dystonia 17
|
|
DYT21
|
dystonia 21, torsion (autosomal dominant)
|
|
DYX1C1
|
dyslexia susceptibility 1 candidate 1
|
|
E2F1
|
E2F transcription factor 1
|
|
ECA1
|
epilepsy, childhood absence 1
|
|
EDN1
|
endothelin 1
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
ELN
|
elastin
|
|
EN2
|
engrailed homeobox 2
|
|
ENG
|
endoglin
|
|
ENO1
|
enolase 1, (alpha)
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ENSA
|
endosulfine alpha
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPC1
|
enhancer of polycomb homolog 1 (Drosophila)
|
|
EPHB2
|
EPH receptor B2
|
|
EPYC
|
epiphycan
|
|
EQTN
|
equatorin, sperm acrosome associated
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERLIN2
|
ER lipid raft associated 2
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETM2
|
essential tremor 2
|
|
EVI5
|
ecotropic viral integration site 5
|
|
EVPL
|
envoplakin
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXOC2
|
exocyst complex component 2
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EYS
|
eyes shut homolog (Drosophila)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F9
|
coagulation factor IX
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAM13A
|
family with sequence similarity 13, member A
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAM3C
|
family with sequence similarity 3, member C
|
|
FAM69A
|
family with sequence similarity 69, member A
|
|
FBN1
|
fibrillin 1
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FCRLB
|
Fc receptor-like B
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FFAR1
|
free fatty acid receptor 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGG
|
fibrinogen gamma chain
|
|
FHIT
|
fragile histidine triad
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKRP
|
fukutin related protein
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXC2
|
forkhead box C2
|
|
FOXE1
|
forkhead box E1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FRAS1
|
Fraser extracellular matrix complex subunit 1
|
|
FSCN1P1
|
fascin actin-bundling protein 1 pseudogene 1
|
|
FSHMD1A
|
facioscapulohumeral muscular dystrophy 1A
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FXN
|
frataxin
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon
|
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALR1
|
galanin receptor 1
|
|
GAS1
|
growth arrest-specific 1
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GATSL3
|
GATS protein-like 3
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GFRA2
|
GDNF family receptor alpha 2
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GGNBP2
|
gametogenetin binding protein 2
|
|
GH1
|
growth hormone 1
|
|
GIMAP1
|
GTPase, IMAP family member 1
|
|
GIMAP4
|
GTPase, IMAP family member 4
|
|
GINGF3
|
gingival fibromatosis, hereditary, 3
|
|
GINS3
|
GINS complex subunit 3 (Psf3 homolog)
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPC3
|
GIPC PDZ domain containing family, member 3
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLC1H
|
glaucoma 1, open angle, H (adult-onset)
|
|
GLC1L
|
glaucoma 1, open angle, L (adult-onset)
|
|
GLS
|
glutaminase
|
|
GLT6D1
|
glycosyltransferase 6 domain containing 1
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB1L
|
guanine nucleotide binding protein (G protein), beta polypeptide 1-like
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GON4L
|
gon-4-like (C. elegans)
|
|
GOPC
|
golgi-associated PDZ and coiled-coil motif containing
|
|
GOT1L1
|
glutamic-oxaloacetic transaminase 1-like 1
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPC5
|
glypican 5
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR174
|
G protein-coupled receptor 174
|
|
GPR180
|
G protein-coupled receptor 180
|
|
GPR35
|
G protein-coupled receptor 35
|
|
GPR50
|
G protein-coupled receptor 50
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
|
GRIA4
|
glutamate receptor, ionotropic, AMPA 4
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRIP1
|
glutamate receptor interacting protein 1
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GRN
|
granulin
|
|
GSDMA
|
gasdermin A
|
|
GSDMB
|
gasdermin B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HABP2
|
hyaluronan binding protein 2
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2
|
|
HARS
|
histidyl-tRNA synthetase
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBBP1
|
hemoglobin, beta pseudogene 1
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCP5
|
HLA complex P5 (non-protein coding)
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDLBP
|
high density lipoprotein binding protein
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHAT
|
hedgehog acyltransferase
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HHIP
|
hedgehog interacting protein
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
|
HIP1
|
huntingtin interacting protein 1
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST1H2BL
|
histone cluster 1, H2bl
|
|
HIST1H2BM
|
histone cluster 1, H2bm
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HK1
|
hexokinase 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLCS
|
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB2
|
high mobility group box 2
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXA9
|
homeobox A9
|
|
HOXB1
|
homeobox B1
|
|
HOXB7
|
homeobox B7
|
|
HOXC4
|
homeobox C4
|
|
HOXD3
|
homeobox D3
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRES1
|
HTLV-1 related endogenous sequence
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSF4
|
heat shock transcription factor 4
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AA5P
|
heat shock protein 90kDa alpha (cytosolic), class A member 5, pseudogene
|
|
HSPA12B
|
heat shock 70kD protein 12B
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR3C
|
5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HYDIN
|
HYDIN, axonemal central pair apparatus protein
|
|
IAPP
|
islet amyloid polypeptide
|
|
IBD5
|
inflammatory bowel disease 5
|
|
IBSP
|
integrin-binding sialoprotein
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDDM17
|
insulin-dependent diabetes mellitus 17
|
|
IDDM8
|
insulin-dependent diabetes mellitus 8
|
|
IDDM9
|
insulin-dependent diabetes mellitus 9
|
|
IDE
|
insulin-degrading enzyme
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNE
|
interferon, epsilon
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IFNL4
|
interferon, lambda 4 (gene/pseudogene)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGKC
|
immunoglobulin kappa constant
|
|
IGL
|
immunoglobulin lambda locus
|
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker)
|
|
IGSF8
|
immunoglobulin superfamily, member 8
|
|
IHH
|
indian hedgehog
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL17A
|
interleukin 17A
|
|
IL17RB
|
interleukin 17 receptor B
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1F10
|
interleukin 1 family, member 10 (theta)
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL7R
|
interleukin 7 receptor
|
|
IMMT
|
inner membrane protein, mitochondrial
|
|
ING4
|
inhibitor of growth family, member 4
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
INTS6
|
integrator complex subunit 6
|
|
IPO5
|
importin 5
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
IRX4
|
iroquois homeobox 4
|
|
IS1
|
Adolescent idiopathic scoliosis
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
|
ITM2A
|
integral membrane protein 2A
|
|
JAK2
|
Janus kinase 2
|
|
JDP2
|
Jun dimerization protein 2
|
|
JPH3
|
junctophilin 3
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNH7
|
potassium channel, voltage gated eag related subfamily H, member 7
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KCNQ4
|
potassium channel, voltage gated KQT-like subfamily Q, member 4
|
|
KCNQ5
|
potassium channel, voltage gated KQT-like subfamily Q, member 5
|
|
KCTD2
|
potassium channel tetramerization domain containing 2
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDR
|
kinase insert domain receptor
|
|
KERA
|
keratocan
|
|
KIAA0196
|
KIAA0196
|
|
KIAA1109
|
KIAA1109
|
|
KIAA1462
|
KIAA1462
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF7
|
kinesin family member 7
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL5B
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF12
|
Kruppel-like factor 12
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L1RE1
|
LINE1 retrotransposable element 1
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
LAMA2
|
laminin, alpha 2
|
|
LBX1
|
ladybird homeobox 1
|
|
LCE3B
|
late cornified envelope 3B
|
|
LCE3C
|
late cornified envelope 3C
|
|
LDB1
|
LIM domain binding 1
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEMD3
|
LEM domain containing 3
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGI2
|
leucine-rich repeat LGI family, member 2
|
|
LHX5
|
LIM homeobox 5
|
|
LIPC
|
lipase, hepatic
|
|
LMAN2L
|
lectin, mannose-binding 2-like
|
|
LMNA
|
lamin A/C
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LOR
|
loricrin
|
|
LOXHD1
|
lipoxygenase homology domains 1
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPAL2
|
lipoprotein, Lp(a)-like 2, pseudogene
|
|
LPAR6
|
lysophosphatidic acid receptor 6
|
|
LPL
|
lipoprotein lipase
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
LRRC37BP1
|
leucine rich repeat containing 37B pseudogene 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM1
|
leucine rich repeat transmembrane neuronal 1
|
|
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing
|
|
LTA
|
lymphotoxin alpha
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LUM
|
lumican
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
|
LY96
|
lymphocyte antigen 96
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MAOA
|
monoamine oxidase A
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAST4
|
microtubule associated serine/threonine kinase family member 4
|
|
MASTL
|
microtubule associated serine/threonine kinase-like
|
|
MBD5
|
methyl-CpG binding domain protein 5
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCDR3
|
macular dystrophy, retinal 3
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MCPH1
|
microcephalin 1
|
|
MDH1
|
malate dehydrogenase 1, NAD (soluble)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEFV
|
Mediterranean fever
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEOX1
|
mesenchyme homeobox 1
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGP
|
matrix Gla protein
|
|
MGST2
|
microsomal glutathione S-transferase 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIEN1
|
migration and invasion enhancer 1
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MIR10B
|
microRNA 10b
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR133B
|
microRNA 133b
|
|
MIR137
|
microRNA 137
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR191
|
microRNA 191
|
|
MIR206
|
microRNA 206
|
|
MIR224
|
microRNA 224
|
|
MIR2682
|
microRNA 2682
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR335
|
microRNA 335
|
|
MIR452
|
microRNA 452
|
|
MIR483
|
microRNA 483
|
|
MIR517C
|
microRNA 517c
|
|
MIR520G
|
microRNA 520g
|
|
MIR522
|
microRNA 522
|
|
MIR671
|
microRNA 671
|
|
MIR9-1
|
microRNA 9-1
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MMEL1
|
membrane metallo-endopeptidase-like 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MOSPD3
|
motile sperm domain containing 3
|
|
MPC1
|
mitochondrial pyruvate carrier 1
|
|
MPO
|
myeloperoxidase
|
|
MRAS
|
muscle RAS oncogene homolog
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRI1
|
methylthioribose-1-phosphate isomerase 1
|
|
MRPS30
|
mitochondrial ribosomal protein S30
|
|
MRX49
|
mental retardation, X-linked 49
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSH2
|
mutS homolog 2
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSMO1
|
methylsterol monooxygenase 1
|
|
MST1
|
macrophage stimulating 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTPAP
|
mitochondrial poly(A) polymerase
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC19
|
mucin 19, oligomeric
|
|
MUS81
|
MUS81 structure-specific endonuclease subunit
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYAS1
|
Myasthenia gravis with thymus hyperplasia
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MYH15
|
myosin, heavy chain 15
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO1A
|
myosin IA
|
|
MYO7A
|
myosin VIIA
|
|
MYO9B
|
myosin IXB
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOZ1
|
myozenin 1
|
|
MYP1
|
myopia 1 (X-linked)
|
|
MYP3
|
myopia 3 (high grade, autosomal dominant)
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NADSYN1
|
NAD synthetase 1
|
|
NANOG
|
Nanog homeobox
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAN
|
neurocan
|
|
NCDN
|
neurochondrin
|
|
NCK2
|
NCK adaptor protein 2
|
|
NCMAP
|
noncompact myelin associated protein
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA7
|
nuclear receptor coactivator 7
|
|
NCSTN
|
nicastrin
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDUFA1
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa
|
|
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase)
|
|
NEGR1
|
neuronal growth regulator 1
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NID1
|
nidogen 1
|
|
NIPA1
|
non imprinted in Prader-Willi/Angelman syndrome 1
|
|
NIT2
|
nitrilase family, member 2
|
|
NKAPL
|
NFKB activating protein-like
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN1
|
neuroligin 1
|
|
NNAT
|
neuronatin
|
|
NOC3L
|
nucleolar complex associated 3 homolog (S. cerevisiae)
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPAS3
|
neuronal PAS domain protein 3
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRG1
|
neuregulin 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
NUP50-AS1
|
NUP50 antisense RNA 1 (head to head)
|
|
OBFC1
|
oligonucleotide/oligosaccharide-binding fold containing 1
|
|
OLIG1
|
oligodendrocyte transcription factor 1
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OLIG3
|
oligodendrocyte transcription factor 3
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPA4
|
optic atrophy 4 (autosomal dominant)
|
|
OPA5
|
optic atrophy 5 (autosomal dominant)
|
|
OPRL1
|
opiate receptor-like 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORM1
|
orosomucoid 1
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OSTM1
|
osteopetrosis associated transmembrane protein 1
|
|
OTSC2
|
otosclerosis 2
|
|
OTSC4
|
otosclerosis 4
|
|
OTX1
|
orthodenticle homeobox 1
|
|
P2RX2
|
purinergic receptor P2X, ligand gated ion channel, 2
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAH
|
phenylalanine hydroxylase
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PARK12
|
Parkinson disease 12 (susceptibility)
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX2
|
paired box 2
|
|
PAX4
|
paired box 4
|
|
PAX6
|
paired box 6
|
|
PCDHA1
|
protocadherin alpha 1
|
|
PCDHGC3
|
protocadherin gamma subfamily C, 3
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PEE1
|
preeclampsia/eclampsia 1
|
|
PEG3-AS1
|
PEG3 antisense RNA 1
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PER2
|
period circadian clock 2
|
|
PGAP3
|
post-GPI attachment to proteins 3
|
|
PGD
|
phosphogluconate dehydrogenase
|
|
PGLYRP1
|
peptidoglycan recognition protein 1
|
|
PGR
|
progesterone receptor
|
|
PHF11
|
PHD finger protein 11
|
|
PHF3
|
PHD finger protein 3
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PHIP
|
pleckstrin homology domain interacting protein
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKP2
|
plakophilin 2
|
|
PLA2G15
|
phospholipase A2, group XV
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLD2
|
phospholipase D2
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLIN1
|
perilipin 1
|
|
PLIN4
|
perilipin 4
|
|
PLN
|
phospholamban
|
|
PLXNA2
|
plexin A2
|
|
PMEL
|
premelanosome protein
|
|
PMM2
|
phosphomannomutase 2
|
|
PNMT
|
phenylethanolamine N-methyltransferase
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
POMGNT1
|
protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
POU2F3
|
POU class 2 homeobox 3
|
|
POU3F4
|
POU class 3 homeobox 4
|
|
POU4F1
|
POU class 4 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PPP3CC
|
protein phosphatase 3, catalytic subunit, gamma isozyme
|
|
PRDM16
|
PR domain containing 16
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PRM3
|
protamine 3
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROM1
|
prominin 1
|
|
PROX1
|
prospero homeobox 1
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRPH
|
peripherin
|
|
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PSEN1
|
presenilin 1
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PSORS4
|
psoriasis susceptibility 4
|
|
PSRC1
|
proline/serine-rich coiled-coil 1
|
|
PTCH1
|
patched 1
|
|
PTCH2
|
patched 2
|
|
PTCHD1
|
patched domain containing 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN21
|
protein tyrosine phosphatase, non-receptor type 21
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
PYY
|
peptide YY
|
|
QPCT
|
glutaminyl-peptide cyclotransferase
|
|
RAB23
|
RAB23, member RAS oncogene family
|
|
RAB29
|
RAB29, member RAS oncogene family
|
|
RAB33B
|
RAB33B, member RAS oncogene family
|
|
RAB38
|
RAB38, member RAS oncogene family
|
|
RAB5B
|
RAB5B, member RAS oncogene family
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAET1L
|
retinoic acid early transcript 1L
|
|
RAMP1
|
receptor (G protein-coupled) activity modifying protein 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP1
|
RAN binding protein 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASEF
|
RAS and EF-hand domain containing
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
RFX6
|
regulatory factor X, 6
|
|
RGS12
|
regulator of G-protein signaling 12
|
|
RGS17
|
regulator of G-protein signaling 17
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RHO
|
rhodopsin
|
|
RIC3
|
RIC3 acetylcholine receptor chaperone
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RIT2
|
Ras-like without CAAX 2
|
|
RLN1
|
relaxin 1
|
|
RLS4
|
Restless legs syndrome 4
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF11
|
ring finger protein 11
|
|
RNF123
|
ring finger protein 123
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPL39L
|
ribosomal protein L39-like
|
|
RPL5
|
ribosomal protein L5
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RRIS
|
Respiratory rhythmicity in sleep
|
|
RS1
|
retinoschisin 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SAX1
|
spastic ataxia 1 (autosomal dominant)
|
|
SBF2
|
SET binding factor 2
|
|
SCA21
|
spinocerebellar ataxia 21
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCRN1
|
secernin 1
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEPT2
|
septin 2
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHOX
|
short stature homeobox
|
|
SHOX2
|
short stature homeobox 2
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIL1
|
SIL1 nucleotide exchange factor
|
|
SIM1
|
single-minded family bHLH transcription factor 1
|
|
SIRPB1
|
signal-regulatory protein beta 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A8
|
solute carrier family 12, member 8
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SLC17A1
|
solute carrier family 17 (organic anion transporter), member 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC1A6
|
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6
|
|
SLC22A11
|
solute carrier family 22 (organic anion/urate transporter), member 11
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A18
|
solute carrier family 22, member 18
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC35D3
|
solute carrier family 35, member D3
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC41A1
|
solute carrier family 41 (magnesium transporter), member 1
|
|
SLC4A5
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 5
|
|
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6
|
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SLI1
|
Specific language impairment QTL, 1
|
|
SLURP1
|
secreted LY6/PLAUR domain containing 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMOC1
|
SPARC related modular calcium binding 1
|
|
SMOC2
|
SPARC related modular calcium binding 2
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNRNP200
|
small nuclear ribonucleoprotein 200kDa (U5)
|
|
SNURF
|
SNRPN upstream reading frame
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORBS1
|
sorbin and SH3 domain containing 1
|
|
SORBS2
|
sorbin and SH3 domain containing 2
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SORT1
|
sortilin 1
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP4
|
Sp4 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPAST
|
spastin
|
|
SPATA5
|
spermatogenesis associated 5
|
|
SPD3
|
Synpolydactyly 3
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome)
|
|
SPG34
|
spastic paraplegia 34 (autosomal dominant)
|
|
SPG38
|
spastic paraplegia 38 (autosomal dominant, Silver syndrome)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SPRR1B
|
small proline-rich protein 1B
|
|
SPRR2A
|
small proline-rich protein 2A
|
|
SPRR2B
|
small proline-rich protein 2B
|
|
SPRR2D
|
small proline-rich protein 2D
|
|
SPRR2E
|
small proline-rich protein 2E
|
|
SPRR2F
|
small proline-rich protein 2F
|
|
SPRR2G
|
small proline-rich protein 2G
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPRR4
|
small proline-rich protein 4
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTB
|
spectrin, beta, erythrocytic
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRY
|
sex determining region Y
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
ST7
|
suppression of tumorigenicity 7
|
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STBMS1
|
Strabismus, susceptibility to, 1
|
|
STIP1
|
stress-induced phosphoprotein 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STX11
|
syntaxin 11
|
|
STX1A
|
syntaxin 1A (brain)
|
|
STX1B
|
syntaxin 1B
|
|
STXBP1
|
syntaxin binding protein 1
|
|
SUOX
|
sulfite oxidase
|
|
SUPT6H
|
suppressor of Ty 6 homolog (S. cerevisiae)
|
|
SYN3
|
synapsin III
|
|
SYT1
|
synaptotagmin I
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAGAP
|
T-cell activation RhoGTPase activating protein
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TATDN2
|
TatD DNase domain containing 2
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBX19
|
T-box 19
|
|
TBX21
|
T-box 21
|
|
TCAP
|
titin-cap
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCFL5
|
transcription factor-like 5 (basic helix-loop-helix)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TCP1
|
t-complex 1
|
|
TDRD1
|
tudor domain containing 1
|
|
TECTA
|
tectorin alpha
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGIF1
|
TGFB-induced factor homeobox 1
|
|
TH
|
tyrosine hydroxylase
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR9
|
toll-like receptor 9
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TMEM170A
|
transmembrane protein 170A
|
|
TMEM18
|
transmembrane protein 18
|
|
TMEM231
|
transmembrane protein 231
|
|
TMEM67
|
transmembrane protein 67
|
|
TMIE
|
transmembrane inner ear
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNXB
|
tenascin XB
|
|
TOM1L2
|
target of myb1-like 2 (chicken)
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPORS
|
topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPCN2
|
two pore segment channel 2
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TPO
|
thyroid peroxidase
|
|
TPRN
|
taperin
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRANK1
|
tetratricopeptide repeat and ankyrin repeat containing 1
|
|
TRB
|
T cell receptor beta locus
|
|
TRD
|
T cell receptor delta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIM35
|
tripartite motif containing 35
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRIP4
|
thyroid hormone receptor interactor 4
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSNAX
|
translin-associated factor X
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TSPYL2
|
TSPY-like 2
|
|
TTK
|
TTK protein kinase
|
|
TTN
|
titin
|
|
TUBA4A
|
tubulin, alpha 4a
|
|
TUBA4B
|
tubulin, alpha 4b
|
|
TUBB
|
tubulin, beta class I
|
|
TUBB1
|
tubulin, beta 1 class VI
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBB4B
|
tubulin, beta 4B class IVb
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNDC2
|
thioredoxin domain containing 2 (spermatozoa)
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCK2
|
uridine-cytidine kinase 2
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UFD1L
|
ubiquitin fusion degradation 1 like (yeast)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UHRF1BP1
|
UHRF1 binding protein 1
|
|
UHRF1BP1L
|
UHRF1 binding protein 1-like
|
|
UMOD
|
uromodulin
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
USF1
|
upstream transcription factor 1
|
|
USH1K
|
Usher syndrome 1K (autosomal recessive)
|
|
USP11
|
ubiquitin specific peptidase 11
|
|
USP7
|
ubiquitin specific peptidase 7 (herpes virus-associated)
|
|
USP9Y
|
ubiquitin specific peptidase 9, Y-linked
|
|
VAX2
|
ventral anterior homeobox 2
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTRNA2-1
|
vault RNA 2-1
|
|
VWF
|
von Willebrand factor
|
|
WDR11
|
WD repeat domain 11
|
|
WDR36
|
WD repeat domain 36
|
|
WDR62
|
WD repeat domain 62
|
|
WDR72
|
WD repeat domain 72
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
YTHDF2
|
YTH N(6)-methyladenosine RNA binding protein 2
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
ZC3H14
|
zinc finger CCCH-type containing 14
|
|
ZDHHC8
|
zinc finger, DHHC-type containing 8
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP57
|
ZFP57 zinc finger protein
|
|
ZFP69
|
ZFP69 zinc finger protein
|
|
ZFYVE26
|
zinc finger, FYVE domain containing 26
|
|
ZNF510
|
zinc finger protein 510
|
|
ZNF782
|
zinc finger protein 782
|
|
ZNF804A
|
zinc finger protein 804A
|
|
ZPBP2
|
zona pellucida binding protein 2
|
